| 
Citations
 | 
   web
Shahar, T., Rozovski, U., Hess, K. R., Hossain, A., Gumin, J., Gao, F., et al. (2017). Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol, 19(5), 660–668.
toggle visibility
Roy, A., Attarha, S., Weishaupt, H., Edqvist, P. - H., Swartling, F. J., Bergqvist, M., et al. (2017). Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. Oncotarget, 8(15), 24815–24827.
toggle visibility
Emery, I. F., Gopalan, A., Wood, S., Chow, K. - H., Battelli, C., George, J., et al. (2017). Expression and function of ABCG2 and XIAP in glioblastomas. J Neurooncol, 133(1), 47–57.
toggle visibility
Batista, K. M. P., Eulate-Beramendi, S. A. de, Pina, K. Y. A. R. de, Figueira, P. R., Canal, A. F., Chasin, J. M. A., et al. (2017). Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone. Folia Neuropathol, 55(1), 14–22.
toggle visibility
Khalifa, J., Tensaouti, F., Lusque, A., Plas, B., Lotterie, J. - A., Benouaich-Amiel, A., et al. (2017). Subventricular zones: new key targets for glioblastoma treatment. Radiat Oncol, 12(1), 67.
toggle visibility